Home › Atopic Dermatitis (Eczema) › Texas
Atopic Dermatitis (Eczema) clinical trials in Texas
18 studies for Atopic Dermatitis (Eczema) are looking for participants at sites in Texas.
Cities in Texas
- San Antonio9 studies
- Dallas8 studies
- Sugar Land5 studies
- Lewisville4 studies
- Houston3 studies
- Arlington3 studies
A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
- Derm Texas, Dallas
- Stryde Research-Epiphany Dermatology, Southlake
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Nov 12, 2026 · NCT07765888Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares
- DCOL Center for Clinical Research, Longview
- Harrison Dermatology, Missouri City
RecruitingObservational study
Ages 12 to 89 · All sexes · Updated Nov 9, 2026 · NCT07645820First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
- Texas Dermatology and Laser Specialists, San Antonio
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Nov 6, 2026 · NCT07527923A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema
- Arlington Research Center, Arlington
- Dermatology Treatment and Research Center, Dallas
- Derm Texas, Dallas
- and 2 more
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Nov 6, 2026 · NCT07783425A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
- Texas Dermatology and Laser Specialists, San Antonio
RecruitingPhase 3
Ages 2 to 11 · All sexes · Updated Nov 5, 2026 · NCT06807281A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
- Investigational Site, Dallas
- Investigational Site, Frisco
- Investigational Site, San Antonio
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07003425This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
- Reveal Research Institute - Dallas- Site Number : 8400012, Dallas
- Austin Institute for Clinical Research, Inc- Site Number : 8400030, Pflugerville
- Complete Dermatology - Sugar Land- Site Number : 8400001, Sugar Land
RecruitingObservational study
Ages 12 and older · All sexes · Updated Nov 2, 2026 · NCT07290803A Study Evaluating TRIV-573 in Atopic Dermatitis
- Triveni Bio Site #9, San Antonio
- Triveni Bio Site #6, San Antonio
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 28, 2026 · NCT07782333Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
- Clinical Site 102, College Station
- Clinical Site 104, San Antonio
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Oct 23, 2026 · NCT07453602Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
- Novartis Investigative Site, Arlington
- Novartis Investigative Site, Cypress
- Novartis Investigative Site, Dallas
- and 2 more
RecruitingPhase 2
Ages 18 to 100 · All sexes · Updated Sep 28, 2026 · NCT06947993Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
- Enveda Investigative Site, Arlington
- Enveda Investigative Site, Houston
- Enveda Investigative Site, San Antonio
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 25, 2026 · NCT07298395A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema)
- ALS Global, Irving
RecruitingPhase 2/3
Ages 18 to 80 · All sexes · Updated Sep 4, 2026 · NCT07355075A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- Progressive Clinical Research, PA, San Antonio
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Aug 28, 2026 · NCT07599813A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 8, Southlake
RecruitingPhase 2
Ages 18 to 74 · All sexes · Updated Aug 12, 2026 · NCT07037901A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
- Enveda Investigative Site, Dallas
- Enveda Investigative Site, San Antonio
- Enveda Investigative Site, Sugar Land
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 6, 2026 · NCT07643766Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis
- UT Health Science Houston, Bellaire
- Center for Clinical Studies, Webster
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Jun 15, 2026 · NCT06397911Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
- Galderma Investigational Site 7082, Cedar Park
- Galderma Investigational Site 8238, Dallas
- Galderma Investigational Site 7062, Edinburg
- and 3 more
RecruitingObservational study
Ages 12 and older · All sexes · Updated Mar 13, 2026 · NCT06988605Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis
- Clinical Investigations of Texas, Dallas
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Dec 19, 2025 · NCT06982352From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.